Tennessee House Bill HB1810

Tennessee 2023-2024 Regular Session

• Introduced: 1/10/24
• Refer: 1/22/24

Caption

AN ACT to amend Tennessee Code Annotated, Title 8; Title 56 and Title 68, relative to accidental fentanyl poisoning.

Impact

The introduction of HB1810 is designed to ensure that individuals suffering from accidental fentanyl poisoning receive the necessary medical benefits without fear of denial based on insurance clauses. By solidifying the definition of accidental fentanyl poisoning in state law and restricting how deaths due to fentanyl can be recorded, this bill aims to provide clarity and support for victims and their families. It looks to elevate the recognition of fentanyl-related cases within medical and legal systems, potentially leading to greater accountability in healthcare provisioning.

Summary

House Bill 1810 aims to amend the Tennessee Code Annotated regarding policies related to accidental fentanyl poisoning. The bill prohibits the issuance, delivery, or amendment of accident and sickness insurance policies that limit or deny payment of benefits if the insured suffers from death or injury caused by accidental fentanyl poisoning. It specifically defines this term to encompass severe medical conditions resulting from fentanyl consumption or fentanyl combined with other substances. This change is set to take effect on January 1, 2024.

Sentiment

The sentiment surrounding HB1810 appears to be generally supportive among healthcare advocates and families affected by fentanyl poisoning, who see it as a necessary safeguard. They argue that it addresses critical care gaps in the existing insurance landscape that could leave victims without support. However, there may be opposition from some insurance providers concerned about the implications this law might have on policy frameworks and liabilities. The potential financial impact on the insurance industry could stir debate among legislators and stakeholders who balance business interests with public health obligations.

Contention

One notable point of contention regarding HB1810 might arise from its implications on how insurance companies structure their policies. Critics could argue that mandating coverage for such specific circumstances might lead to higher premiums or stricter underwriting practices across the board. Additionally, defining fentanyl-related deaths uniquely raises questions about the classification of substance use disorders in public health data, which may affect broader discussions on drug policy and healthcare reform.